SavedAdd your journal

Journals / Turkish Journal of Biology / 2014 / Cilt: 38 - Sayı: 6

Evaluation of MUC1, CK20, and hTERT expression in peripheral blood of gastrointestinal cancer patients in search of diagnostic criteria

Sibel KÜÇÜKYILDIRIM
Beril ERDEM
Emel SAĞLAR
Zülfikar POLAT
Hatice MERGEN
Pages
848–857
Publication Date
2014-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, combination of these 3 tumor-specific mRNA markers would increase the detection rate and may be clinically helpful in predicting tumor presence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The goal of this study was to identify the optimal marker or marker combinations for detection of gastrointestinal malignancies using reverse-transcriptase polymerase chain (RT-PCR) reaction.
📊
Key Findings & Data:To detect the presence of tumors, we analyzed mucin 1 (MUC1), cytokeratin 19 (CK19), cytokeratin 20 (CK20), and human telomerase reverse transcriptase (hTERT) mRNA in the peripheral blood of 31 patients with gastrointestinal (esophagus, stomach, and colorectal) cancer and 30 healthy individuals.
💡
Conclusion & Impact:As a result, combination of these 3 tumor-specific mRNA markers would increase the detection rate and may be clinically helpful in predicting tumor presence.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gastrointestinal cancer · reverse-transcriptase PCR · Gastrointestinal cancer

Abstract

The goal of this study was to identify the optimal marker or marker combinations for detection of gastrointestinal malignancies using reverse-transcriptase polymerase chain (RT-PCR) reaction. To detect the presence of tumors, we analyzed mucin 1 (MUC1), cytokeratin 19 (CK19), cytokeratin 20 (CK20), and human telomerase reverse transcriptase (hTERT) mRNA in the peripheral blood of 31 patients with gastrointestinal (esophagus, stomach, and colorectal) cancer and 30 healthy individuals. In RT-PCR analysis of the peripheral blood, 77.4% (24/31), 61.29% (19/31), and 45.16% (14/31) of cancer patients were positive for MUC1, CK20, and hTERT mRNA, respectively. According to our results, any one of these mRNA markers is a predictor of the presence of gastrointestinal tumors (P < 0.001) and colorectal tumors (P < 0.05). However, they did not have predictive potential for presence of metastasis in gastrointestinal tumors. As a result, combination of these 3 tumor-specific mRNA markers would increase the detection rate and may be clinically helpful in predicting tumor presence.

Özet

The goal of this study was to identify the optimal marker or marker combinations for detection of gastrointestinal malignancies using reverse-transcriptase polymerase chain (RT-PCR) reaction. To detect the presence of tumors, we analyzed mucin 1 (MUC1), cytokeratin 19 (CK19), cytokeratin 20 (CK20), and human telomerase reverse transcriptase (hTERT) mRNA in the peripheral blood of 31 patients with gastrointestinal (esophagus, stomach, and colorectal) cancer and 30 healthy individuals. In RT-PCR analysis of the peripheral blood, 77.4% (24/31), 61.29% (19/31), and 45.16% (14/31) of cancer patients were positive for MUC1, CK20, and hTERT mRNA, respectively. According to our results, any one of these mRNA markers is a predictor of the presence of gastrointestinal tumors (P < 0.001) and colorectal tumors (P < 0.05). However, they did not have predictive potential for presence of metastasis in gastrointestinal tumors. As a result, combination of these 3 tumor-specific mRNA markers would increase the detection rate and may be clinically helpful in predicting tumor presence.

🔖

Cite This Article

KÜÇÜKYILDIRIM, S., ERDEM, B., SAĞLAR, E., POLAT, Z., MERGEN, H. (2014). Evaluation of MUC1, CK20, and hTERT expression in peripheral blood of gastrointestinal cancer patients in search of diagnostic criteria. Turkish Journal of Biology, Cilt: 38 - Sayı: 6, 848–857. https://ajindex.com/articles/181632

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Alix-Panabières C, Pantel K (2013). Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59: 110–118.
  2. Anker P, Mulcahy H, Chen XQ, Stroun M (1999). Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metast Rev 18: 65–73.
  3. Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP (2004). MUC1 and nuclear β-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 10: 2790–2796.
  4. Bednarz-Knoll N, Alix-Panabières C, Pantel K (2011). Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 13: 228. Böckmann B, Grill HJ, Giesing M (2001). Molecular characterization of minimal residual cancer cells in patients with solid tumors. Biomol Eng 17: 95–111.
  5. Boyle P, Levin B (2008).
  6. World Cancer Report. Lyon, France: WHO Press.
  7. Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P (1995). Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Brit J Cancer 71: 278–281.
  8. Chelly J, Concordet JP, Kaplan JC, Kahn A (1989). Illegitimate transcription: transcription of any gene in any cell type. P Natl Acad Sci USA 86: 2617-2621.
  9. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaffer P, Mulcahy HE, Meyer P, Stroun M et al. (2000). Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6: 3823–3826.
  10. Conzelmann M, Linnemann U, Berger MR (2005). Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use. Int J Colorectal Dis 20: 137–146.
  11. Dandachi N, Balic M, Stanzer S, Halm M, Resel M, Hinterleitner TA, Samonigg H, Bauernhofer T (2005). Critical evaluation of real- time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients. J Mol Diagn 7: 631–637. de Cremoux P, Extra JM, Denis MG, Pierga JY, Bourstyn E, Nos C, Clough KB, Boudou E, Martin EC, Müller A et al. (2000). Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res 6: 3117–3122.
  12. Denis MG, Lipart C, Leborgne J, LeHur PA, Galmiche JP, Denis M, Ruud E, Truchaud A, Lustenberger P (1997). Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int J Cancer 7